Go to deals
Private Equity | Healthcare

DCN Dx has received a growth equity investment from Martis Capital

DCN Dx, a leading provider of contract development services, has received a growth equity investment from Martis Capital.

DCN Dx offers contract development services for clients seeking to explore, develop and commercialize rapid diagnostic tests related to lateral flow assay. DCN Dx supports an array of customers including global diagnostics manufacturers, nonprofits seeking tests for low-resource settings and start-ups launching diagnostic-based products. Over the past 15 years, DCN Dx has successfully developed more than 100 rapid diagnostic tests for its customers.

Martis Capital is a private equity firm which manages more than US$1.2 billion of equity and is focused exclusively on investing in middle-market growth companies in the healthcare industry.

One of Oaklins’ teams in the USA, together with Pegasus Capital, served as a financial advisor to DCN Dx, in connection with a growth equity investment from Martis Capital.

Service
M&A sell-side
Parties

Talk to the deal team

 Bradford A. Adams

Bradford A. Adams

Managing Director
Boston, United States
Oaklins TM Capital
 Michael S. Goldman

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital
 James  McLaren

James McLaren

Managing Director
New York, United States
Oaklins TM Capital

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more
PSG Equity has made a strategic growth investment in Rodeo Software
Private Equity | TMT

PSG Equity has made a strategic growth investment in Rodeo Software

PSG Equity has made a strategic growth investment in Rodeo Software B.V., the leading project management SaaS platform, to accelerate its growth through increased GTM investment and geographical expansion.

Learn more
Agar Scientific has been acquired by Calibre Scientific
Private Equity | Healthcare

Agar Scientific has been acquired by Calibre Scientific

Agar Scientific Ltd. (Agar) has been sold to Molecular Dimensions Limited, a subsidiary of Calibre Scientific, Inc., a US-based life sciences company, owned by international private investment firm StoneCalibre.

Learn more